We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$134B
AUM Growth
+$14.8B
Cap. Flow
+$2.42B
Cap. Flow %
1.81%
Top 10 Hldgs %
25.29%
Holding
4,017
New
232
Increased
1,652
Reduced
1,816
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Financials 9.02%
3 Healthcare 7.82%
4 Industrials 6.8%
5 Consumer Discretionary 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
3451
Wayfair
W
$13.9B
$226K ﹤0.01%
3,658
-2,072
-36% -$108K
RVMD icon
3452
PUT
Revolution Medicines
RVMD
$43.3B
$225K ﹤0.01%
+10,000
New +$240K
EFR
3453
Eaton Vance Senior Floating-Rate Fund
EFR
$318M
$225K ﹤0.01%
17,745
+1,230
+7% +$15K
KSA icon
3454
iShares MSCI Saudi Arabia ETF
KSA
$625M
$224K ﹤0.01%
5,298
+102
+2% +$4K
XHS icon
3455
State Street SPDR S&P Health Care Services ETF
XHS
$207M
$224K ﹤0.01%
+2,521
New +$211K
CCB icon
3456
Coastal Financial
CCB
$774M
$224K ﹤0.01%
5,041
DNOW icon
3457
DNOW Inc
DNOW
$2.95B
$224K ﹤0.01%
19,770
-1,159
-6% -$12.7K
VRDN icon
3458
Viridian Therapeutics
VRDN
$2.49B
$223K ﹤0.01%
10,228
-4,936
-33% -$77.9K
NN icon
3459
NextNav
NN
$3.29B
$223K ﹤0.01%
+50,000
New +$226K
PLL
3460
DELISTED
Piedmont Lithium
PLL
$222K ﹤0.01%
7,871
-15,499
-66% -$455K
DAY
3461
DELISTED
Dayforce
DAY
$222K ﹤0.01%
3,309
+98
+3% +$6.69K
NMT icon
3462
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$130M
$222K ﹤0.01%
21,100
-3,500
-14% -$34.5K
TPHD icon
3463
Timothy Plan High Dividend Stock ETF
TPHD
$371M
$222K ﹤0.01%
6,692
+16
+0.2% +$501
MATV icon
3464
Mativ Holdings
MATV
$667M
$221K ﹤0.01%
+14,437
New +$195K
NRP icon
3465
Natural Resource Partners
NRP
$1.36B
$221K ﹤0.01%
2,387
-410
-15% -$31.4K
WEA
3466
Western Asset Premier Bond Fund
WEA
$125M
$221K ﹤0.01%
20,448
+8,776
+75% +$90.8K
PFD
3467
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$220K ﹤0.01%
22,307
+5,500
+33% +$51.7K
GIL icon
3468
Gildan
GIL
$10.6B
$220K ﹤0.01%
+6,656
New +$216K
TLRY icon
3469
Tilray
TLRY
$640M
$219K ﹤0.01%
9,533
+1,629
+21% +$31.4K
IVT icon
3470
InvenTrust Properties
IVT
$2.62B
$219K ﹤0.01%
8,651
-4,189
-33% -$104K
RXI icon
3471
iShares Global Consumer Discretionary ETF
RXI
$274M
$219K ﹤0.01%
+1,374
New +$205K
KARS icon
3472
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$80.9M
$217K ﹤0.01%
8,462
-407
-5% -$10.2K
ENOV icon
3473
Enovis
ENOV
$1.48B
$217K ﹤0.01%
3,866
-345
-8% -$17.2K
PNRG icon
3474
PrimeEnergy Resources
PNRG
$316M
$216K ﹤0.01%
2,035
+31
+2% +$3.31K
NARI
3475
DELISTED
Inari Medical, Inc. Common Stock
NARI
$216K ﹤0.01%
+3,333
New +$201K

Similar funds

Raymond James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Raymond James & Associates held 4,017 positions worth $134B, up 12% from $119B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q4 2023 filing shows 232 new, 1,652 increased, 1,816 reduced and 191 closed positions. Its largest new stake was Delek US: 515,324 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2023 buy was Delek US: 515,324 shares worth $13.3M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $219M increase.
  • Raymond James & Associates's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $124M.
  • Raymond James & Associates fully exited Kayne Anderson NextGen Energy & Infrastructure, Inc. in Q4 2023, selling an estimated $22.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $134B portfolio in Q4 2023.
  • Raymond James & Associates opened 232 new positions and closed 191 in Q4 2023.
  • Raymond James & Associates's portfolio value rose 12% quarter-over-quarter to $134B.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.